Center Laboratories, Inc.

Taipei Exchange 4123.TWO

Center Laboratories, Inc. Revenue for the year ending December 31, 2023: USD 45.41 M

Center Laboratories, Inc. Revenue is USD 45.41 M for the year ending December 31, 2023, a 81.32% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Center Laboratories, Inc. Revenue for the year ending December 31, 2022 was USD 25.04 M, a 38.82% change year over year.
Center Laboratories, Inc. Revenue for the year ending December 31, 2021 was USD 18.04 M, a -29.23% change year over year.
Center Laboratories, Inc. Revenue for the year ending December 31, 2020 was USD 25.49 M, a -46.96% change year over year.
Center Laboratories, Inc. Revenue for the year ending December 31, 2019 was USD 48.06 M, a -93.21% change year over year.

Key data

Date	Revenue	Gross Profit	Operating Income	EBIT

Taipei Exchange: 4123.TWO

Center Laboratories, Inc.

CEO	Ms. Su-Chi Wang
IPO Date	Dec. 31, 2007
Location	Taiwan
Headquarters	No. 3-2, Yuanyuan Street
Employees	182
Sector	Health Care
Industries Pharmaceuticals

Description

Center Laboratories, Inc. engages in the manufacture and trading of various medicines in Taiwan. It engages in the research and development of small molecule drugs; manufacture and sale of pharmaceuticals; development of proteins and antibodies; and pharmaceutical CDMO, medical device, nutritional health and agribiotechnology, stem cell and immune cell therapy, and industry investment fund and venture capital businesses. The company was founded in 1959 and is headquartered in Taipei, Taiwan.

Key trends

Past 5 years